EPH SPA (EPH.MI) Fundamental Analysis & Valuation

BIT:EPH • IT0005623845

Current stock price

0.0854 EUR
0 (-4.04%)
Last:

This EPH.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EPH.MI Profitability Analysis

1.1 Basic Checks

  • EPH had negative earnings in the past year.
  • EPH had a negative operating cash flow in the past year.
  • In the past 5 years EPH always reported negative net income.
  • In the past 5 years EPH always reported negative operating cash flow.
EPH.MI Yearly Net Income VS EBIT VS OCF VS FCFEPH.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • The Return On Assets of EPH (141.53%) is better than 100.00% of its industry peers.
Industry RankSector Rank
ROA 141.53%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EPH.MI Yearly ROA, ROE, ROICEPH.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

  • EPH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EPH.MI Yearly Profit, Operating, Gross MarginsEPH.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -500 -1K

0

2. EPH.MI Health Analysis

2.1 Basic Checks

  • There is no outstanding debt for EPH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EPH.MI Yearly Shares OutstandingEPH.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022
EPH.MI Yearly Total Debt VS Total AssetsEPH.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

  • EPH has an Altman-Z score of -213.56. This is a bad value and indicates that EPH is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -213.56, EPH is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -213.56
ROIC/WACCN/A
WACCN/A
EPH.MI Yearly LT Debt VS Equity VS FCFEPH.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

  • EPH has a Current Ratio of 0.02. This is a bad value and indicates that EPH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EPH's Current ratio of 0.02 is on the low side compared to the rest of the industry. EPH is outperformed by 92.31% of its industry peers.
  • A Quick Ratio of 0.02 indicates that EPH may have some problems paying its short term obligations.
  • The Quick ratio of EPH (0.02) is worse than 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
EPH.MI Yearly Current Assets VS Current LiabilitesEPH.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 10M 20M 30M 40M

0

3. EPH.MI Growth Analysis

3.1 Past

  • EPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.48%, which is quite impressive.
EPS 1Y (TTM)97.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPH.MI Yearly Revenue VS EstimatesEPH.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2020 2021 2022 50M 100M 150M 200M
EPH.MI Yearly EPS VS EstimatesEPH.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 -500M -1B -1.5B -2B

0

4. EPH.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EPH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EPH.MI Price Earnings VS Forward Price EarningsEPH.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EPH.MI Per share dataEPH.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -10K -20K -30K -40K -50K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. EPH.MI Dividend Analysis

5.1 Amount

  • No dividends for EPH!.
Industry RankSector Rank
Dividend Yield 0%

EPH.MI Fundamentals: All Metrics, Ratios and Statistics

EPH SPA

BIT:EPH (3/17/2026, 7:00:00 PM)

0.0854

0 (-4.04%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)09-16
Earnings (Next)04-01
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners30.5%
Ins Owner ChangeN/A
Market Cap2.48M
Revenue(TTM)N/A
Net Income(TTM)313.20K
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-50736.77
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.4
TBVpS-0.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 141.53%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -213.56
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-83.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1372.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.57%
OCF growth 3YN/A
OCF growth 5YN/A

EPH SPA / EPH.MI Fundamental Analysis FAQ

What is the fundamental rating for EPH stock?

ChartMill assigns a fundamental rating of 0 / 10 to EPH.MI.


What is the valuation status for EPH stock?

ChartMill assigns a valuation rating of 0 / 10 to EPH SPA (EPH.MI). This can be considered as Overvalued.


What is the profitability of EPH stock?

EPH SPA (EPH.MI) has a profitability rating of 1 / 10.